EU and UK Cosmetics Compliance in 2026: Where the Two Regimes Have Actually Split

Three weeks ago, a French haircare brand came to us convinced their dossier was ready for UK market entry. Their EU safety reports were solid, their CPNP notifications filed and current, their Responsible Person properly established in Lyon. We had to break some uncomfortable news: none of that transfers automatically across the Channel anymore. It hasn’t for over four years.

That conversation happens with surprising regularity. The default working assumption among many European cosmetics manufacturers — especially brands that built their compliance infrastructure before December 2020 — is that the UK and EU are still broadly the same regulatory environment. They’re not. And the gap between them is wider in 2026 than most teams realise.

The Assumption That’s Quietly Burning Brands

When the UK’s transition period ended on 31 December 2020, Great Britain (England, Scotland, Wales) stopped applying EU cosmetics law and began operating under its own retained version of Regulation (EC) No 1223/2009. The text was identical at the point of departure. The problem is that the two regimes have been amended independently ever since — by the European Commission on one side, and by UK statutory instruments on the other.

The result is two legal environments that look similar on the surface but diverge in specific, material ways. A brand selling in both the EU and UK is now managing two separate competent authorities, two notification portals, two sets of Responsible Person obligations, and two amendment trajectories that are not synchronised. As of mid-2026, at least five significant technical divergences have emerged between the two regimes. That number will grow.

This matters most for mid-sized European brands: large multinationals have dedicated regulatory teams tracking both systems; very small brands often don’t sell in the UK at all. It’s the brands in the middle — doing €2–€20 million in annual revenue, selling across several European markets and into the UK — that most often discover their compliance gaps at the worst possible moment.

Where EU and UK Cosmetics Rules Have Actually Diverged

Ingredient restrictions

This is where divergence bites hardest. The EU has continued to amend Annexes II through VI of Regulation (EC) No 1223/2009 — the lists governing prohibited substances, restricted substances, and permitted colorants, preservatives, and UV filters. The UK is updating its equivalent Annexes independently through its own regulatory process. A substance may carry different concentration limits, or even a different prohibition status, depending on which side of the Channel your product is placed on the market.

The most concrete recent example is microplastics. The EU’s restriction on intentionally added microplastics under REACH Regulation (EC) No 1907/2006 — specifically Entry 78 of Annex XVII, which began a phased implementation from October 2023 — applies to rinse-off cosmetics containing certain synthetic polymer particles, including microbeads and loose glitter. UK-REACH has not adopted an equivalent restriction. A rinse-off product formulation that is non-compliant in the EU may be entirely legal in Great Britain. For brands formulating a single SKU for both markets, that asymmetry is not theoretical.

UV filter approvals are another live issue. The EU authorises new UV filters through a scientific opinion process involving the SCCS (Scientific Committee on Consumer Safety) followed by Commission Regulation amendments to Annex VI. The UK evaluates its own applications separately through the MHRA and the Office for Product Safety and Standards (OPSS). An innovative UV filter approved in the EU in 2024 or 2025 may not yet have GB authorisation, and vice versa.

Notification portals

EU products must be notified via the CPNP — the Cosmetics Products Notification Portal managed by the European Commission. UK products require a separate notification through OPSS. Two portals, two submissions, two sets of data requirements, and no data-sharing or mutual recognition between them. Regulatory time for each notification runs roughly 1–3 hours per product, and the clocks on each system are completely independent.

A brand that migrated CPNP notifications to a new product version in 2024 but didn’t update the corresponding UK OPSS record is technically non-compliant on the UK side, even if the product is identical.

Responsible Person requirements

Under Regulation (EC) No 1223/2009, the Responsible Person must be established within the European Union. Under the UK Cosmetics Regulation, the RP for products placed on the Great Britain market must be established in Great Britain. A company registered in Lyon or Berlin cannot serve as the UK Responsible Person — a UK-based entity must take on that statutory role separately.

This single fact catches more European brands off-guard than almost anything else. Third-party UK RP services typically cost £800–£3,000 per year depending on portfolio size, scope of review, and the level of documentation support included. It’s a manageable cost, but only if you’ve planned for it.

Safety report format and evolving guidance

Both regimes require a cosmetic safety report under Article 10 of their respective regulations, and both require the safety assessor to hold qualifying professional credentials — typically a degree in pharmacy, toxicology, medicine, or an equivalent discipline. The structural requirements (Part A covering safety information; Part B containing assessor conclusions) are substantively similar.

But the MHRA and OPSS have published guidance on UK safety report expectations that in some respects diverges from SCCS scientific guidance used on the EU side. A well-constructed EU safety report will usually satisfy UK requirements, but that alignment is not guaranteed as both sets of guidance documents continue to be updated independently. Assessors working across both markets are tracking the delta; brands relying on an assessor who only follows EU guidance may not be.

Labelling

EU labelling must include the name and address of the Responsible Person established in the EU. UK labelling must show the name and address of the UK RP. For brands operating in both markets, this typically means either two separate label versions or a dual-RP label design that accommodates both addresses within available space.

There’s also a practical print-run economics issue. Brands that batch-print labels for EU and UK in a single run will need to absorb redesign and re-plate costs whenever either jurisdiction amends a mandatory labelling element — and they won’t necessarily amend at the same time.

The Northern Ireland Situation Is Its Own Problem

The Windsor Framework, which came into effect in 2023, governs Northern Ireland’s unique regulatory position. Products placed on the market in Northern Ireland must comply with EU rules — EU ingredient restrictions, EU Responsible Person address on the label, and CPNP notification. For cosmetics regulatory purposes, Northern Ireland is treated as if it remains within the EU’s single market.

This creates a potential three-track compliance situation for any brand with meaningful UK distribution: EU rules for continental sales, UK-GB rules for England/Scotland/Wales, and EU rules again for Northern Ireland. In practice, most brands serving NI handle it by defaulting to the EU-compliant version of their product for that segment, but this only works if the EU-compliant formulation is also legal in the GB market. Given the divergences described above, that can’t be assumed without a specific cross-check.

Northern Ireland accounts for roughly 2.9% of the UK population — not a market to optimise around, but enough to create real compliance exposure if it’s ignored in your distribution planning.

What Dual Compliance Actually Costs

Based on the regulatory situations we work through with European brands pursuing both markets, the additional overhead of maintaining genuine separate EU and UK compliance for an established cosmetics range breaks down approximately as follows:

• UK Responsible Person designation: £800–£3,000 per year for a third-party RP service
• Separate OPSS notification: 1–3 hours of regulatory time per product per notification event
• Label versioning: €500–€2,500 per product line in design and print management, depending on run sizes and whether a dual-RP layout is viable
• Safety report review for UK-specific guidance alignment: typically 2–4 additional assessor hours per product where divergence is material
• Ingredient cross-checking against both Annex versions: 1–2 days of regulatory time per new formulation review

For a brand with 20 active SKUs selling across both markets, maintaining genuine dual compliance adds a realistic floor of €15,000–€30,000 per year in direct and indirect compliance costs. That’s before any reformulation costs triggered by a restriction that applies in one jurisdiction but not the other — which can be considerably higher if the affected ingredient is in a core formulation.

The brands that absorb these costs most efficiently are the ones that build them into their product development pipeline from day one, rather than retrofitting compliance after the product range is already on shelf in both markets.

Your Five-Step Compliance Review for Both Markets

If you haven’t formally audited your dual-market compliance posture since the UK amended its own Annexes, here’s where to start:

1. Cross-reference your active ingredients against both EU and UK Annex versions. Focus especially on any substance that was added, amended, or had its concentration limit changed in either jurisdiction after 1 January 2021. The divergence isn’t exhaustive, but it’s material in specific categories: preservatives, UV filters, some fragrance components, and microplastics-adjacent materials.

2. Confirm your UK Responsible Person designation covers your current product portfolio. An RP agreement signed in 2021 for an initial SKU range may not extend to products launched since then. New SKUs need to be explicitly covered by the UK RP’s designation document.

3. Verify your OPSS notifications are complete and current. Not every CPNP-notified product necessarily has a corresponding OPSS record, particularly for brands that migrated during the original transition window and haven’t actively maintained the UK portal since. Check both product and formula version records.

4. Audit your labels for dual-RP legibility and mandatory element compliance. If you’re running a single label for both markets, confirm it meets both EU and UK requirements — including any elements that have been independently amended since the original dual-label design was signed off.

5. Assess your NI distribution explicitly. If any portion of your UK sales reaches Northern Ireland, confirm those products satisfy EU 1223/2009 requirements in full — not just UK-GB standards. CPNP notification and EU RP labelling apply.

This isn’t a one-time exercise. Both regimes are moving targets, and neither publishes a consolidated diff of what’s changed since Brexit. Building a quarterly review into your regulatory calendar — cross-referencing both the EU Official Journal and UK statutory instruments for cosmetics-relevant amendments — is now baseline hygiene for any dual-market brand.

---

The brands navigating this well have accepted that EU and UK are separate jurisdictions requiring separate tracking, separate documentation, and separate regulatory relationships. They’re not waiting for the divergence to reverse or for some future harmonisation agreement to resolve the complexity. Four years of evidence suggests neither is coming. The smarter move is to treat UK compliance as a parallel programme to your EU programme — same rigour, different rulebook.

---

Written by Nour Abochama, Quality & Regulatory Advisor, Care Europe | VP Operations, Qalitex. Learn more about our team

Talk to our team about EU market entry Contact us

Related from our network

• EU Cosmetics Ingredient Testing for US Market Entry — ISO 17025-accredited testing services for European cosmetics brands seeking FDA compliance in the US market.
• Health Canada NHP Registration Support for European Brands — Canadian regulatory compliance and laboratory testing for European natural health and cosmetics brands entering the Canadian market.